les-resultats-de-phase-iii-de-german-breast-group-gbg-demontrent-une-activite-superieure-en-cas-de-cancer-du-sein-de-stade-precoce-a-haut-risque-du-nab-paclitaxel-abraxane-par-rapport-a

les-resultats-de-phase-iii-de-german-breast-group-gbg-demontrent-une-activite-superieure-en-cas-de-cancer-du-sein-de-stade-precoce-a-haut-risque-du-nab-paclitaxel-abraxane-par-rapport-a